Method
Infected (ICUi) and non-infected ICU patients (ICU Control-ICUc) and normal volunteers (C) had CD64 levels measured by the Accellix CD64 instrument. Measurements were calculated as 'CD64 index', i.e. the ratio between the fluorescence of the PMN population and the fluorescence of control beads. ICU infection, ICU control and normal control patients' results can be seen in Figure 1 .
Results
Sixty patients were studied (ICUi-17, ICUc-13 and C-30). CD64 Index levels were higher (mean ± SEM) in ICU infection patients then ICU control and normal control patients (2.49 ± 0.42 vs. 1.28 ± 0.3 vs. 0.56 ± 0.02. p = 0.03 for ICUi vs. ICUc, p < 0.001 for ICUi vs. C).
Conclusion
CD64 Index levels are higher in infected than noninfected ICU patients. Accellix CD64 is a promising instrument to differentiate infected from non-infected ICU patients in a timely manner.
